Redeye comments on GiG ahead of its Q3-results (due 8 November) where we expect continued sequential...
Redeye provides an update following the Q3 report. Doro's performance exceeded our expectations, dri...
Redeye states that Catella's Q3 2022 report was weaker than expected, although the core continues to...
Redeye states the Q3 report is a good data point that the profitability "turn-around" story is under...
Redeye updates its estimates following Netmore’s Q3 report, where sales managed to beat our forecast...
Redeye updates its estimates and valuation following ADDvise releasing its Q3 2023 report.
Redeye views the performance of Tobii Dynavox favorably as the expectations continue to be exceeded.
Redeye comments on Medivir's Q3 report and on the new positive data from 18 patients in the liver ca...
3% organic growth and improved margins EBITDA down 2-5% for '23e-'25e 52-60% below historical multip...
Watch CEO Lars Lindell present the company’s Q3 report.
Management presented its quarterly earnings, adding context to the recent capital markets day (CMD),...
Another strong quarter, order intake up 33%, EBITA margin 9.
Scanfil's Q3 net sales and EBIT were close to consensus expectations, while its operating profit mar...
Redeye retains its positive view of Sdiptech following a Q3 report that exceeded our expectations.
Redeye keeps its positive view of Fortnox despite lowering its Base Case, mostly due to us using a h...
Redeye strengthens its positive view of Avensia following a strong Q3, with an EBIT significantly ab...
Redeye retains its positive view of Addnode following the Q3 report, with an EBITA coming in somewha...
An in line report on adj. EBITA and -8% org growth (ABGSCe -7%) Cost reductions bear fruit, adj.
Amido AB (”Amido” eller ”Bolaget”) är en ledande leverantör av mjukvara som integrerar passersystem ...
Redeye sees a Q3 report from CombinedX with solid underlying data but higher external costs than exp...
